Zobrazeno 1 - 10
of 146
pro vyhledávání: '"11"'
Autor:
Cristoforo Silvestri, Ester Pagano, Sébastien Lacroix, Tommaso Venneri, Claudia Cristiano, Antonio Calignano, Olga A. Parisi, Angelo A. Izzo, Vincenzo Di Marzo, Francesca Borrelli
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology 11 (2020). doi:10.3389/fphar.2020.585096
info:cnr-pdr/source/autori:Silvestri, Cristoforo; Pagano, Ester; Lacroix, Sebastien; Venneri, Tommaso; Cristiano, Claudia; Calignano, Antonio; Parisi, Olga A.; Izzo, Angelo A.; Di Marzo, Vincenzo; Borrelli, Francesca/titolo:Fish Oil, Cannabidiol and the Gut Microbiota: An Investigation in a Murine Model of Colitis/doi:10.3389%2Ffphar.2020.585096/rivista:Frontiers in Pharmacology/anno:2020/pagina_da:/pagina_a:/intervallo_pagine:/volume:11
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology 11 (2020). doi:10.3389/fphar.2020.585096
info:cnr-pdr/source/autori:Silvestri, Cristoforo; Pagano, Ester; Lacroix, Sebastien; Venneri, Tommaso; Cristiano, Claudia; Calignano, Antonio; Parisi, Olga A.; Izzo, Angelo A.; Di Marzo, Vincenzo; Borrelli, Francesca/titolo:Fish Oil, Cannabidiol and the Gut Microbiota: An Investigation in a Murine Model of Colitis/doi:10.3389%2Ffphar.2020.585096/rivista:Frontiers in Pharmacology/anno:2020/pagina_da:/pagina_a:/intervallo_pagine:/volume:11
In experimental colitis, administration of fish oil (FO) and the non-psychoactive cannabinoid, cannabidiol (CBD) reduces inflammation and ameliorates behavioural disturbances, two conditions associated with alterations in the gut microbiota (dysbiosi
Autor:
Raphaël Roduit, Florence Mehl, Yasmine Derradji, Irmela Mantel, Claude Schweizer, Angelica Borgo, Edwige Forestier, Jacopo Guidotti, Olga Kirsch, Frédéric Burdet, Patrice Waridel
Publikováno v:
Frontiers in Pharmacology
Frontiers in pharmacology, vol. 11, pp. 594087
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in pharmacology, vol. 11, pp. 594087
Frontiers in Pharmacology, Vol 11 (2020)
The standard treatment for neovascular age-related macular degeneration (nAMD) consists of intravitreal anti-vascular endothelial growth factors (VEGF). However, for some patients, even maximal anti-VEGF treatment does not entirely suppress exudative
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology, Vol 11 (2020)
Allergic contact dermatitis (ACD) is characterized by itching, skin inflammation, and allergic responses caused by release of immunoglobulin E and T helper 2-specific cytokines. The aim of this study is to investigate the ameliorative and synergic ef
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, 2020, 11, pp.89-100. ⟨10.3389/fphar.2020.01305⟩
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology, Frontiers, 2020, 11, pp.89-100. ⟨10.3389/fphar.2020.01305⟩
Frontiers in Pharmacology, 2020, 11, pp.89-100. ⟨10.3389/fphar.2020.01305⟩
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology, Frontiers, 2020, 11, pp.89-100. ⟨10.3389/fphar.2020.01305⟩
Interstitial cystitis/Bladder Pain Syndrome (IC/BPS) is a chronic inflammatory disease characterized by visceral pain and voiding symptoms. IC/BPS is still an unsolved enigma with ineffective diagnosis criteria and treatment. A main limitation in IC/
Autor:
Zi Wang, Lei Zhang, Zhengshan Tang, Jianhui Song, Xiaojuan Xiao, Dehui Xiong, Mao Ye, Jing Liu
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology, Vol 11 (2020)
Ulcerative colitis (UC) is an idiopathic inflammatory bowel disease (IBD) that causes long-lasting inflammation and ulcers in the innermost lining of the colon and rectum. Previous studies demonstrated that resveratrol suppresses colitis and colon ca
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology
Frontiers in Pharmacology
Purpose: Our recent research is dedicated to finding effective drugs for the treatment of knee osteoarthritis (KOA) from traditional Chinese medicine and trying to make full use of modern science and technology to uncover the mechanisms and targets b
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology, Vol 12 (2021)
Background and Purpose: Sepsis is a life-threatening condition associated with secondary multiple organ injury. Acute lung injury (ALI) caused by sepsis has high morbidity and mortality in critical care units. Lianhua Qingwen (LHQW) is a traditional
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 11 (2021)
Frontiers in Pharmacology, Vol 11 (2021)
Neuropathic pain (NP) is one of the intractable complications of spinal cord injury (SCI), with poor prognosis and seriously affects the quality of life of patients. This study aims to determine the treatment effect and mechanism of multimodal therap
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 11 (2021)
Frontiers in Pharmacology, Vol 11 (2021)
Background: Spinal cord injury (SCI) is a devastating condition that leads to paralysis, disability and even death in severe cases. Inflammation, apoptosis and oxidative stress in neurons are key pathogenic processes in SCI. Catalpol (CTP), an iridoi
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Frontiers in Pharmacology
Frontiers in Pharmacology
Type I interferon (IFN-I) plays a critical role in the antiviral immune response. However, viruses have developed different strategies to suppress the production of IFN-I for its own escape and amplification. Therefore, promoting the production of IF